Thiazolidinediones, like metformin, inhibit respiratory complex I: a common mechanism contributing to their antidiabetic actions?
- PMID: 15047621
- DOI: 10.2337/diabetes.53.4.1052
Thiazolidinediones, like metformin, inhibit respiratory complex I: a common mechanism contributing to their antidiabetic actions?
Abstract
Metformin and thiazolidinediones (TZDs) are believed to exert their antidiabetic effects via different mechanisms. As evidence suggests that both impair cell respiration in vitro, this study compared their effects on mitochondrial functions. The activity of complex I of the respiratory chain, which is known to be affected by metformin, was measured in tissue homogenates that contained disrupted mitochondria. In homogenates of skeletal muscle, metformin and TZDs reduced the activity of complex I (30 mmol/l metformin, -15 +/- 2%; 100 micromol/l rosiglitazone, -54 +/- 7; and 100 micromol/l pioglitazone, -12 +/- 4; P < 0.05 each). Inhibition of complex I was confirmed by reduced state 3 respiration of isolated mitochondria consuming glutamate + malate as substrates for complex I (30 mmol/l metformin, -77 +/- 1%; 100 micromol/l rosiglitazone, -24 +/- 4; and 100 micromol/l pioglitazone, -18 +/- 5; P < 0.05 each), whereas respiration with succinate feeding into complex II was unaffected. In line with inhibition of complex I, 24-h exposure of isolated rat soleus muscle to metformin or TZDs reduced cell respiration and increased anaerobic glycolysis (glucose oxidation: 270 micromol/l metformin, -30 +/- 9%; 9 micromol/l rosiglitazone, -25 +/- 8; and 9 micromol/l pioglitazone, -45 +/- 3; lactate release: 270 micromol/l metformin, +84 +/- 12; 9 micromol/l rosiglitazone, +38 +/- 6; and 9 micromol/l pioglitazone, +64 +/- 11; P < 0.05 each). As both metformin and TZDs inhibit complex I activity and cell respiration in vitro, similar mitochondrial actions could contribute to their antidiabetic effects.
Similar articles
-
Fenofibrate impairs rat mitochondrial function by inhibition of respiratory complex I.J Pharmacol Exp Ther. 2004 Oct;311(1):109-14. doi: 10.1124/jpet.104.068312. Epub 2004 May 27. J Pharmacol Exp Ther. 2004. PMID: 15166256
-
Acute mitochondrial actions of glitazones on the liver: a crucial parameter for their antidiabetic properties.Cell Physiol Biochem. 2011;28(5):899-910. doi: 10.1159/000335804. Epub 2011 Dec 15. Cell Physiol Biochem. 2011. PMID: 22178942
-
Acute exposure to rosiglitazone does not affect glucose transport in intact human skeletal muscle.Metabolism. 2010 Feb;59(2):224-30. doi: 10.1016/j.metabol.2009.07.016. Epub 2009 Sep 17. Metabolism. 2010. PMID: 19765783
-
Thiazolidinediones: effects on the development and progression of type 2 diabetes and associated vascular complications.Diabetes Metab Res Rev. 2009 Feb;25(2):112-26. doi: 10.1002/dmrr.937. Diabetes Metab Res Rev. 2009. PMID: 19219860 Review.
-
Effects of pioglitazone and rosiglitazone combined with metformin on body weight in people with diabetes.Diabetes Obes Metab. 2009 Dec;11(12):1091-9. doi: 10.1111/j.1463-1326.2009.01087.x. Epub 2009 Sep 17. Diabetes Obes Metab. 2009. PMID: 19765050 Review.
Cited by
-
AMPK as a mediator of tissue preservation: time for a shift in dogma?Nat Rev Endocrinol. 2024 May 17. doi: 10.1038/s41574-024-00992-y. Online ahead of print. Nat Rev Endocrinol. 2024. PMID: 38760482 Review.
-
Metformin: A Dual-Role Player in Cancer Treatment and Prevention.Int J Mol Sci. 2024 Apr 6;25(7):4083. doi: 10.3390/ijms25074083. Int J Mol Sci. 2024. PMID: 38612893 Free PMC article. Review.
-
The troglitazone derivative EP13 disrupts energy metabolism through respiratory chain complex I inhibition in breast cancer cells and potentiates the antiproliferative effect of glycolysis inhibitors.Cancer Cell Int. 2024 Apr 10;24(1):132. doi: 10.1186/s12935-024-03319-z. Cancer Cell Int. 2024. PMID: 38594745 Free PMC article.
-
Hypothalamic AMP-Activated Protein Kinase as a Whole-Body Energy Sensor and Regulator.Endocrinol Metab (Seoul). 2024 Feb;39(1):1-11. doi: 10.3803/EnM.2024.1922. Epub 2024 Feb 14. Endocrinol Metab (Seoul). 2024. PMID: 38356211 Free PMC article.
-
Mitochondrial complex I inhibition triggers NAD+-independent glucose oxidation via successive NADPH formation, "futile" fatty acid cycling, and FADH2 oxidation.Geroscience. 2024 Aug;46(4):3635-3658. doi: 10.1007/s11357-023-01059-y. Epub 2024 Jan 25. Geroscience. 2024. PMID: 38267672 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials